Korean Circ J.  2020 Mar;50(3):264-266. 10.4070/kcj.2019.0413.

A New Member of Myocardial Ischemia-Reperfusion (MI/R) Associated miRNAs, miR-484: Its Potential Cardiac Protection Role

• Seok H

• KMID: 2470911
• DOI: http://doi.org/10.4070/kcj.2019.0413

Abstract

No abstract available.

MeSH Terms

MicroRNAs*
MicroRNAs

Reference

1. Fiedler J, Thum T. MicroRNAs in myocardial infarction. Arterioscler Thromb Vasc Biol. 2013; 33:201–205.

2. Boon RA, Dimmeler S. MicroRNAs in myocardial infarction. Nat Rev Cardiol. 2015; 12:135–142.

3. Euler G. Good and bad sides of TGFβ-signaling in myocardial infarction. Front Physiol. 2015; 6:66.

4. Zhu L, Chen S, Chen Y. Unraveling the biological functions of Smad7 with mouse models. Cell Biosci. 2011; 1:44.

5. Sucharov C, Bristow MR, Port JD. miRNA expression in the failing human heart: functional correlates. J Mol Cell Cardiol. 2008; 45:185–192.

6. van Rooij E, Sutherland LB, Liu N, et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci U S A. 2006; 103:18255–18260.

7. Liu H, Li S, Jiang W, Li Y. MiR-484 protects rat myocardial cells from ischemia-reperfusion injury by inhibiting caspase-3 and caspase-9 during apoptosis. Korean Circ J. 2020; 50:250–263.

8. Wang K, Long B, Jiao JQ, et al. miR-484 regulates mitochondrial network through targeting Fis1. Nat Commun. 2012; 3:781.

9. Olson EN. MicroRNAs as therapeutic targets and biomarkers of cardiovascular disease. Sci Transl Med. 2014; 6:239ps3.

10. Zhou SS, Jin JP, Wang JQ, et al. miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges. Acta Pharmacol Sin. 2018; 39:1073–1084.

11. Gabisonia K, Prosdocimo G, Aquaro GD, et al. MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs. Nature. 2019; 569:418–422.